Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Clinical Stage III Gastric Cancer AJCC v8 · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage IV Gastric Cancer AJCC v8 · Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Locally Advanced Gastric Carcinoma · Locally Advanced Gastroesophageal Junction Adenocarcinoma · Locally Advanced Malignant Solid Neoplasm · Metastatic Gastric Carcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Metastatic Malignant Solid Neoplasm · Unresectable Gastric Carcinoma · Unresectable Gastroesophageal Junction Adenocarcinoma · Unresectable Malignant Solid Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Site Public Contact) · askmdanderson@mdanderson.org · 866-632-6789
Contact: Principal Investigator (Funda Meric-Bernstam)

Study leads

Funda Meric-Bernstam
Principal Investigator
University of Texas MD Anderson Cancer Center LAO

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Little Rock, United States · Little Rock, United States

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Anchorage, United States